Last week the National Health Council held its annual Science of Patient Engagement Symposium, an annual event where research leaders convene to share their experiences, accomplishments, best practices, and resulting translational impacts on the science of patient engagement.
September NHC Communications affinity group meeting Event Time: 12:00 – 1:30 p.m. ET Event Location: In-Person This meeting is for NHC members only. Contact Jennifer Schleman, Senior Vice President, Communications […]
The NHC team will present an overview of the 2021 NHC Revenue Report findings to NHC patient group members.
Registration Is Now Open for the 2022 NHC Washington Representatives Retreat! By: Alicia Pinckney, Senior Coordinator, Marketing Communications The National Health Council (NHC)’s 2022 Washington Representatives Retreat is now open […]
Physician Fee Schedule 2023 Letter (PDF) September 6, 2022 The Honorable Chiquita Brooks-LaSure Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services 7500 Security Blvd Baltimore, […]
GUEST BLOG: PDUFA, PATIENT CENTRICITY AND DIVERSITY IN DRUG R&D By: Anthony Yanni, MD, Senior Vice president and Global Head of Patient Centricity at Astellas Pharma, Inc. Two major pieces […]
On behalf of the National Health Council (NHC), I am writing to urge Congress to improve health care access, equity, and innovation to help patients, now and in the future, as reconciliation legislation is considered in the Senate and House. This letter provides feedback on certain elements of the Inflation Reduction Act (IRA).
March 2022 Communications Affinity Group Virtual Meeting Event Time: 3:00 – 4:00 p.m. ET Event Location: Virtual This meeting is for NHC members only. Contact Jennifer Schleman, Vice President, Marketing […]
During this three-part series, our guest speakers will introduce attendees to key topics related to digital health.
Statement for the Record: FDA User Fee Reauthorization: Ensuring Safe and Effective Drugs and Biologics
Statement for the Record: FDA User Fee Reauthorization: Ensuring Safe and Effective Drugs and Biologics February 3, 2022, 10:30 a.m. United States House Committee on Energy and CommerceRandall L. RuttaChief […]